Clinical Trials Browser

Phase 3 × Tablets × Other hematologic neoplasm × Clear all

NCT05907057 2025-04-11

An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04233034 2024-11-27

CLVer

Phase 3 Completed

113 enrolled 42 charts

Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

NCT01827930 2020-12-31

MIM

Phase 3 Terminated

68 enrolled 13 charts

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT00748189 2019-06-25

COMPLEMENT 1

Phase 3 Terminated

447 enrolled 32 charts

LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell